Need help finding what you are looking for?
Contact Us
PUBLISHER: Grand View Research | PRODUCT CODE: 1842198
PUBLISHER: Grand View Research | PRODUCT CODE: 1842198
Body Fluid Collection And Diagnostics Market Size, Share & Trends Analysis Report By Sample (Blood, Saliva, Urine, Cerebrospinal Fluid), By Product (Tests/Services), By Technology, By Application, By Region, And Segment Forecasts, 2025 - 2033
PUBLISHED:
PAGES: 120 Pages
DELIVERY TIME: 2-10 business days
SELECT AN OPTION
Body Fluid Collection And Diagnostics Market Summary
The global body fluid collection and diagnostics market size was estimated at USD 34.35 billion in 2024 and is anticipated to reach USD 61.99 billion by 2033, growing at a CAGR of 6.87% from 2025 to 2033. Rapid results, cost-effectiveness, and early prognosis of diseases are some of the factors contributing to the growth of the body fluid collection and diagnostics industry.
Advances in in-vitro diagnostic techniques are also playing a big role, as they make testing more accurate and efficient, encouraging wider use. For instance, in May 2022, TECHKON GmbH introduced a new method for analyzing body fluids that can assess medical parameters and diagnose diseases at the same time, making testing faster and more comprehensive.
The growing number of blood-related disorders is a key factor driving the demand for blood collection devices. Diseases such as anemia, sickle cell disease, hemophilia, and clotting disorders are becoming more common, along with blood cancers such as myeloma, lymphoma, and leukemia. In the U.S., blood cancer is particularly devastating, taking a life every nine minutes, which adds up to about 157 deaths each day or more than six every hour. In 2023, it's estimated that nearly 57,380 people in the U.S. will die from leukemia, lymphoma, or myeloma, accounting for almost 9.4% of all cancer-related deaths.
An estimated 437,337 individuals in the U.S. are either living with or in remission from leukemia, while around 879,242 people are in the same condition with lymphoma. Blood clots affect approximately 900,000 Americans each year, leading to about 100,000 deaths annually. Notably, fewer than one in four people show any noticeable signs or symptoms of a blood clot, underscoring the silent but significant impact of this condition.
The growing focus on early disease detection has significantly driven demand in the body fluid collection and diagnostics industry. Samples such as saliva, blood, urine, and semen are increasingly used to analyze biomarkers and other indicators for accurate and timely diagnosis. Moreover, numerous advancements and innovations have been made globally, further enhancing testing capabilities and expanding the range of conditions that can be detected through fluid-based diagnostics. For instance, in July 2021, Abbott announced of launching Panbio COVID-19 Antigen Self-Test in India to strengthen its rapid diagnostics product portfolio. It would support testing needs at work, at clinics, and at home. Further recently, In May 2024, the U.S. FDA approved the Rika Plasma Donation System featuring the iNomi Nomogram developed by Terumo Corporation. This product helps determine plasma collection volume based on an individual donor's weight, height, and hematocrit level at the time of donation.
Alzheimer's Disease (AD) is a severe neurodegenerative disease that requires the identification of precise biomarkers. The development and validation of early-stage biomarkers is a high research priority for existing diagnostics that can detect AD. Body-fluid biomarkers accurately reflect a synaptic failure in the brain and, as a result, could help improve diagnostic accuracy, track the course of the disease, and act as indicators for evaluating the effectiveness of early-onset disease-modifying therapies. In May 2022, the FDA authorized the marketing of a new test that could improve the diagnosis of AD. The Lumipulse test evaluates the ratio of -amyloid 1-40 and-amyloid 1-42 concentrations found in the human cerebral spinal fluid, which can help doctors in determining if a patient is expected to have amyloid plaques, a characteristic symptom of AD.
Body fluid samples contain a large number of naturally occurring biomarker proteins, which effectively show cancer progression. They are also utilized to find these biomarkers in order to validate the presence of cancer. For instance, in January 2022, scientists from the University of Illinois developed a tool that could detect cancer biomarkers in the body fluid samples. The quantification and detection of cancer-associated molecular biomarkers in such body fluids would help for minimally invasive cancer detection.
Furthermore, technological innovations in in-vitro diagnostics, such as high-throughput testing, automation, and integration of AI, have significantly enhanced diagnostic accuracy and efficiency. These advancements enable faster turnaround times and improved sensitivity, making body fluid diagnostic tools indispensable for modern healthcare. The availability of such innovative solutions supports the global adoption of these technologies.
Global Body Fluid Collection And Diagnostics Market Segmentation
This report forecasts revenue growth at global, regional & country levels and provides an analysis on the industry trends in each of the sub-segments from 2021 to 2033. For the purpose of this study, Grand View Research has segmented the global body fluid collection and diagnostics market report on the basis of sample, technology, application, product and region:
- Sample Outlook (Revenue, USD Million, 2021 - 2033)
- Blood
- Saliva
- Urine
- Cerebrospinal Fluid
- Product Outlook (Revenue, USD Million, 2021 - 2033)
- Tests/Services
- Kits & Consumables
- Instruments
- Technology Outlook (Revenue, USD Million, 2021 - 2033)
- Next Generation Sequencing (NGS)
- Polymerase Chain Reaction (PCR)
- Fluorescence in situ hybridization (FISH)
- Others
- Application Outlook (Revenue, USD Million, 2021 - 2033)
- Diagnostics & Monitoring
- Therapeutic Decision Making
- Prognostics & Screening
- Regional Outlook (Revenue, USD Million, 2021 - 2033)
- North America
- U.S.
- Canada
- Mexico
- Europe
- UK
- Germany
- France
- Italy
- Spain
- Denmark
- Sweden
- Norway
- Asia Pacific
- China
- Japan
- India
- Australia
- Thailand
- South Korea
- Latin America
- Brazil
- Argentina
- Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
- Kuwait
Product Code: GVR-4-68040-019-8
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Market Segmentation & Scope
- 1.2. Segment Definitions
- 1.2.1. Sample
- 1.2.2. Product
- 1.2.3. Technology
- 1.2.4. Application
- 1.2.5. Regional scope
- 1.2.6. Estimates and forecasts timeline
- 1.3. Research Methodology
- 1.4. Information Procurement
- 1.4.1. Purchased database
- 1.4.2. GVR's internal database
- 1.4.3. Secondary sources
- 1.4.4. Primary research
- 1.4.5. Details of primary research
- 1.4.5.1. Data for primary interviews in North America
- 1.4.5.2. Data for primary interviews in Europe
- 1.4.5.3. Data for primary interviews in Asia Pacific
- 1.4.5.4. Data for primary interviews in Latin America
- 1.4.5.5. Data for Primary interviews in MEA
- 1.5. Information or Data Analysis
- 1.5.1. Data analysis models
- 1.6. Market Formulation & Validation
- 1.7. Model Details
- 1.7.1. Commodity flow analysis (Model 1)
- 1.7.2. Approach 1: Commodity flow approach
- 1.7.3. Volume price analysis (Model 2)
- 1.7.4. Approach 2: Volume price analysis
- 1.8. List of Secondary Sources
- 1.9. List of Primary Sources
- 1.10. Objectives
Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Outlook
- 2.2.1. Sample Outlook
- 2.2.2. Product outlook
- 2.2.3. Technology outlook
- 2.2.4. Application outlook
- 2.2.5. Regional outlook
- 2.3. Competitive Insights
Chapter 3. Body Fluid Collection And Diagnostics Market Variables, Trends & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent market outlook
- 3.1.2. Related/ancillary market outlook
- 3.2. Market Dynamics
- 3.2.1. Market driver analysis
- 3.2.1.1. Increasing adoption of body fluid and collection kits for rapid diagnosis
- 3.2.1.2. Increasing prevalence of non-communicable diseases
- 3.2.1.3. Technological Advancements in Diagnostic Testing
- 3.2.2. Market restraint analysis
- 3.2.2.1. Lack of expertise to conduct at-home testing
- 3.2.2.2. High cost of instruments
- 3.2.1. Market driver analysis
- 3.3. Body Fluid Collection And Diagnostics Market Analysis Tools
- 3.3.1. Industry Analysis - Porter's
- 3.3.1.1. Supplier power
- 3.3.1.2. Buyer power
- 3.3.1.3. Substitution threat
- 3.3.1.4. Threat of new entrant
- 3.3.1.5. Competitive rivalry
- 3.3.2. PESTEL Analysis
- 3.3.2.1. Political landscape
- 3.3.2.2. Technological landscape
- 3.3.2.3. Economic landscape
- 3.3.1. Industry Analysis - Porter's
Chapter 4. Body Fluid Collection And Diagnostics Market: Sample Estimates & Trend Analysis
- 4.1. Sample Market Share, 2024 & 2033
- 4.2. Segment Dashboard
- 4.3. Global Body Fluid Collection And Diagnostics Market by Sample Outlook
- 4.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
- 4.5. Blood
- 4.5.1. Market estimates and forecasts 2021 to 2033 (USD million)
- 4.6. Saliva
- 4.6.1. Market estimates and forecasts 2021 to 2033 (USD Million)
- 4.7. Urine
- 4.7.1. Market estimates and forecasts 2021 to 2033 (USD Million)
- 4.8. Cerebrospinal Fluid
- 4.8.1. Market estimates and forecasts 2021 to 2033 (USD Million)
Chapter 5. Body Fluid Collection And Diagnostics Market: Product Estimates & Trend Analysis
- 5.1. Product Market Share, 2024 & 2033
- 5.2. Segment Dashboard
- 5.3. Global Body Fluid Collection And Diagnostics Market by Product Outlook
- 5.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
- 5.5. Tests/Services
- 5.5.1. Market estimates and forecasts 2021 to 2033 (USD million)
- 5.6. Kits & Consumables
- 5.6.1. Market estimates and forecasts 2021 to 2033 (USD Million)
- 5.7. Instruments
- 5.7.1. Market estimates and forecasts 2021 to 2033 (USD Million)
Chapter 6. Body Fluid Collection And Diagnostics Market: Technology Estimates & Trend Analysis
- 6.1. Technology Market Share, 2024 & 2033
- 6.2. Segment Dashboard
- 6.3. Global Body Fluid Collection And Diagnostics Market by Technology Outlook
- 6.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
- 6.5. Next-Generation Sequencing
- 6.5.1. Market estimates and forecasts 2021 to 2033 (USD million)
- 6.6. Polymerase Chain Reaction (PCR)
- 6.6.1. Market estimates and forecasts 2021 to 2033 (USD Million)
- 6.7. Fluorescence in situ hybridization (FISH)
- 6.7.1. Market estimates and forecasts 2021 to 2033 (USD Million)
- 6.8. Others
- 6.8.1. Market estimates and forecasts 2021 to 2033 (USD Million)
Chapter 7. Body Fluid Collection And Diagnostics Market: Application Estimates & Trend Analysis
- 7.1. Application Market Share, 2024 & 2033
- 7.2. Segment Dashboard
- 7.3. Global Body Fluid Collection And Diagnostics Market by Application Outlook
- 7.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
- 7.5. Diagnostics & Monitoring
- 7.5.1. Market estimates and forecasts 2021 to 2033 (USD million)
- 7.6. Therapeutic Decision Making
- 7.6.1. Market estimates and forecasts 2021 to 2033 (USD Million)
- 7.7. Prognostics & Screening
- 7.7.1. Market estimates and forecasts 2021 to 2033 (USD Million)
Chapter 8. Body Fluid Collection And Diagnostics Market: Regional Estimates & Trend Analysis
- 8.1. Regional Market Share Analysis, 2024 & 2033
- 8.2. Regional Market Dashboard
- 8.3. Global Regional Market Snapshot
- 8.4. Market Size & Forecasts Trend Analysis, 2021 to 2033
- 8.5. North America
- 8.5.1. U.S.
- 8.5.1.1. Key country dynamics
- 8.5.1.2. Regulatory framework/ reimbursement structure
- 8.5.1.3. Competitive scenario
- 8.5.1.4. U.S. market estimates and forecasts 2021 to 2033 (USD Million)
- 8.5.2. Canada
- 8.5.2.1. Key country dynamics
- 8.5.2.2. Regulatory framework/ reimbursement structure
- 8.5.2.3. Competitive scenario
- 8.5.2.4. Canada market estimates and forecasts 2021 to 2033 (USD Million)
- 8.5.3. Mexico
- 8.5.3.1. Key country dynamics
- 8.5.3.2. Regulatory framework/ reimbursement structure
- 8.5.3.3. Competitive scenario
- 8.5.3.4. Mexico market estimates and forecasts 2021 to 2033, (USD Million)
- 8.5.1. U.S.
- 8.6. Europe
- 8.6.1. UK
- 8.6.1.1. Key country dynamics
- 8.6.1.2. Regulatory framework/ reimbursement structure
- 8.6.1.3. Competitive scenario
- 8.6.1.4. UK market estimates and forecasts 2021 to 2033 (USD Million)
- 8.6.2. Germany
- 8.6.2.1. Key country dynamics
- 8.6.2.2. Regulatory framework/ reimbursement structure
- 8.6.2.3. Competitive scenario
- 8.6.2.4. Germany market estimates and forecasts 2021 to 2033 (USD Million)
- 8.6.3. France
- 8.6.3.1. Key country dynamics
- 8.6.3.2. Regulatory framework/ reimbursement structure
- 8.6.3.3. Competitive scenario
- 8.6.3.4. France market estimates and forecasts 2021 to 2033 (USD Million)
- 8.6.4. Italy
- 8.6.4.1. Key country dynamics
- 8.6.4.2. Regulatory framework/ reimbursement structure
- 8.6.4.3. Competitive scenario
- 8.6.4.4. Italy market estimates and forecasts 2021 to 2033 (USD Million)
- 8.6.5. Spain
- 8.6.5.1. Key country dynamics
- 8.6.5.2. Regulatory framework/ reimbursement structure
- 8.6.5.3. Competitive scenario
- 8.6.5.4. Spain market estimates and forecasts 2021 to 2033 (USD Million)
- 8.6.6. Norway
- 8.6.6.1. Key country dynamics
- 8.6.6.2. Regulatory framework/ reimbursement structure
- 8.6.6.3. Competitive scenario
- 8.6.6.4. Norway market estimates and forecasts 2021 to 2033 (USD Million)
- 8.6.7. Sweden
- 8.6.7.1. Key country dynamics
- 8.6.7.2. Regulatory framework/ reimbursement structure
- 8.6.7.3. Competitive scenario
- 8.6.7.4. Sweden market estimates and forecasts 2021 to 2033 (USD Million)
- 8.6.8. Denmark
- 8.6.8.1. Key country dynamics
- 8.6.8.2. Regulatory framework/ reimbursement structure
- 8.6.8.3. Competitive scenario
- 8.6.8.4. Denmark market estimates and forecasts 2021 to 2033 (USD Million)
- 8.6.1. UK
- 8.7. Asia Pacific
- 8.7.1. Japan
- 8.7.1.1. Key country dynamics
- 8.7.1.2. Regulatory framework/ reimbursement structure
- 8.7.1.3. Competitive scenario
- 8.7.1.4. Japan market estimates and forecasts 2021 to 2033 (USD Million)
- 8.7.2. China
- 8.7.2.1. Key country dynamics
- 8.7.2.2. Regulatory framework/ reimbursement structure
- 8.7.2.3. Competitive scenario
- 8.7.2.4. China market estimates and forecasts 2021 to 2033 (USD Million)
- 8.7.3. India
- 8.7.3.1. Key country dynamics
- 8.7.3.2. Regulatory framework/ reimbursement structure
- 8.7.3.3. Competitive scenario
- 8.7.3.4. India market estimates and forecasts 2021 to 2033 (USD Million)
- 8.7.4. Australia
- 8.7.4.1. Key country dynamics
- 8.7.4.2. Regulatory framework/ reimbursement structure
- 8.7.4.3. Competitive scenario
- 8.7.4.4. Australia market estimates and forecasts 2021 to 2033 (USD Million)
- 8.7.5. South Korea
- 8.7.5.1. Key country dynamics
- 8.7.5.2. Regulatory framework/ reimbursement structure
- 8.7.5.3. Competitive scenario
- 8.7.5.4. South Korea market estimates and forecasts 2021 to 2033 (USD Million)
- 8.7.6. Thailand
- 8.7.6.1. Key country dynamics
- 8.7.6.2. Regulatory framework/ reimbursement structure
- 8.7.6.3. Competitive scenario
- 8.7.6.4. Thailand market estimates and forecasts 2021 to 2033 (USD Million)
- 8.7.1. Japan
- 8.8. Latin America
- 8.8.1. Brazil
- 8.8.1.1. Key country dynamics
- 8.8.1.2. Regulatory framework/ reimbursement structure
- 8.8.1.3. Competitive scenario
- 8.8.1.4. Brazil market estimates and forecasts 2021 to 2033 (USD Million)
- 8.8.2. Argentina
- 8.8.2.1. Key country dynamics
- 8.8.2.2. Regulatory framework/ reimbursement structure
- 8.8.2.3. Competitive scenario
- 8.8.2.4. Argentina market estimates and forecasts 2021 to 2033 (USD Million)
- 8.8.1. Brazil
- 8.9. MEA
- 8.9.1. South Africa
- 8.9.1.1. Key country dynamics
- 8.9.1.2. Regulatory framework/ reimbursement structure
- 8.9.1.3. Competitive scenario
- 8.9.1.4. South Africa market estimates and forecasts 2021 to 2033 (USD Million)
- 8.9.2. Saudi Arabia
- 8.9.2.1. Key country dynamics
- 8.9.2.2. Regulatory framework/ reimbursement structure
- 8.9.2.3. Competitive scenario
- 8.9.2.4. Saudi Arabia market estimates and forecasts 2021 to 2033 (USD Million)
- 8.9.3. UAE
- 8.9.3.1. Key country dynamics
- 8.9.3.2. Regulatory framework/ reimbursement structure
- 8.9.3.3. Competitive scenario
- 8.9.3.4. UAE market estimates and forecasts 2021 to 2033 (USD Million)
- 8.9.4. Kuwait
- 8.9.4.1. Key country dynamics
- 8.9.4.2. Regulatory framework/ reimbursement structure
- 8.9.4.3. Competitive scenario
- 8.9.4.4. Kuwait market estimates and forecasts 2021 to 2033 (USD Million)
- 8.9.1. South Africa
Chapter 9. Competitive Landscape
- 9.1. Recent Developments & Impact Analysis, By Key Market Participants
- 9.2. Company/Competition Categorization
- 9.3. Vendor Landscape
- 9.3.1. Key company market share analysis, 2024
- 9.3.2. Thermo Fisher Scientific Inc.
- 9.3.2.1. Company overview
- 9.3.2.2. Financial performance
- 9.3.2.3. Product benchmarking
- 9.3.2.4. Strategic initiatives
- 9.3.3. Bio-Rad Laboratories
- 9.3.3.1. Company overview
- 9.3.3.2. Financial performance
- 9.3.3.3. Product benchmarking
- 9.3.3.4. Strategic initiatives
- 9.3.4. Illumina, Inc
- 9.3.4.1. Company overview
- 9.3.4.2. Financial performance
- 9.3.4.3. Product benchmarking
- 9.3.4.4. Strategic initiatives
- 9.3.5. Guardant Health
- 9.3.5.1. Company overview
- 9.3.5.2. Financial performance
- 9.3.5.3. Product benchmarking
- 9.3.5.4. Strategic initiatives
- 9.3.6. QIAGEN
- 9.3.6.1. Company overview
- 9.3.6.2. Financial performance
- 9.3.6.3. Product benchmarking
- 9.3.6.4. Strategic initiatives
- 9.3.7. Johnson & Johnson
- 9.3.7.1. Company overview
- 9.3.7.2. Financial performance
- 9.3.7.3. Product benchmarking
- 9.3.7.4. Strategic initiatives
- 9.3.8. Laboratory Corporation of America Holdings
- 9.3.8.1. Company overview
- 9.3.8.2. Financial performance
- 9.3.8.3. Product benchmarking
- 9.3.8.4. Strategic initiatives
- 9.3.9. Biocept Inc
- 9.3.9.1. Company overview
- 9.3.9.2. Financial performance
- 9.3.9.3. Product benchmarking
- 9.3.9.4. Strategic initiatives
- 9.3.10. F. Hoffmann-La Roche Ltd.
- 9.3.10.1. Company overview
- 9.3.10.2. Financial performance
- 9.3.10.3. Product benchmarking
- 9.3.10.4. Strategic initiatives
- 9.3.11. MDxHealth SA.
- 9.3.11.1. Company overview
- 9.3.11.2. Financial performance
- 9.3.11.3. Product benchmarking
- 9.3.11.4. Strategic initiatives
Product Code: GVR-4-68040-019-8
List of Tables
- Table 1 List of Secondary Sources
- Table 2 List of Abbreviations
- Table 3 Global body fluid collection and diagnostics market, by Sample, 2021 - 2033 (USD Million)
- Table 4 Global body fluid collection and diagnostics market, by Technology, 2021 - 2033 (USD Million)
- Table 5 Global body fluid collection and diagnostics market, by Product, 2021 - 2033 (USD Million)
- Table 6 Global body fluid collection and diagnostics market, by Application, 2021 - 2033 (USD Million)
- Table 7 North America body fluid collection and diagnostics market, by Country, 2021 - 2033 (USD Million)
- Table 8 North America body fluid collection and diagnostics market, by Sample, 2021 - 2033 (USD Million)
- Table 9 North America body fluid collection and diagnostics market, by Technology, 2021 - 2033 (USD Million)
- Table 10 North America body fluid collection and diagnostics market, by Product, 2021 - 2033 (USD Million)
- Table 11 North America body fluid collection and diagnostics market, by Application, 2021 - 2033 (USD Million)
- Table 12 U.S. body fluid collection and diagnostics market, by Sample, 2021 - 2033 (USD Million)
- Table 13 U.S. body fluid collection and diagnostics market, by Technology, 2021 - 2033 (USD Million)
- Table 14 U.S. body fluid collection and diagnostics market, by Product, 2021 - 2033 (USD Million)
- Table 15 U.S. body fluid collection and diagnostics market, by Application, 2021 - 2033 (USD Million)
- Table 16 Canada body fluid collection and diagnostics market, by Sample, 2021 - 2033 (USD Million)
- Table 17 Canada body fluid collection and diagnostics market, by Technology, 2021 - 2033 (USD Million)
- Table 18 Canada body fluid collection and diagnostics market, by Product, 2021 - 2033 (USD Million)
- Table 19 Canada body fluid collection and diagnostics market, by Application, 2021 - 2033 (USD Million)
- Table 20 Mexico body fluid collection and diagnostics market, by Sample, 2021 - 2033 (USD Million)
- Table 21 Mexico body fluid collection and diagnostics market, by Technology, 2021 - 2033 (USD Million)
- Table 22 Mexico body fluid collection and diagnostics market, by Product, 2021 - 2033 (USD Million)
- Table 23 Mexico body fluid collection and diagnostics market, by Application, 2021 - 2033 (USD Million)
- Table 24 Europe body fluid collection and diagnostics market, by Country, 2021 - 2033 (USD Million)
- Table 25 Europe body fluid collection and diagnostics market, by Sample, 2021 - 2033 (USD Million)
- Table 26 Europe body fluid collection and diagnostics market, by Technology, 2021 - 2033 (USD Million)
- Table 27 Europe body fluid collection and diagnostics market, by Product, 2021 - 2033 (USD Million)
- Table 28 Europe body fluid collection and diagnostics market, by Application, 2021 - 2033 (USD Million)
- Table 29 Germany body fluid collection and diagnostics market, by Sample, 2021 - 2033 (USD Million)
- Table 30 Germany body fluid collection and diagnostics market, by Technology, 2021 - 2033 (USD Million)
- Table 31 Germany body fluid collection and diagnostics market, by Product, 2021 - 2033 (USD Million)
- Table 32 Germany body fluid collection and diagnostics market, by Application, 2021 - 2033 (USD Million)
- Table 33 UK body fluid collection and diagnostics market, by Sample, 2021 - 2033 (USD Million)
- Table 34 UK body fluid collection and diagnostics market, by Technology, 2021 - 2033 (USD Million)
- Table 35 UK body fluid collection and diagnostics market, by Product, 2021 - 2033 (USD Million)
- Table 36 UK body fluid collection and diagnostics market, by Application, 2021 - 2033 (USD Million)
- Table 37 France body fluid collection and diagnostics market, by Sample, 2021 - 2033 (USD Million)
- Table 38 France body fluid collection and diagnostics market, by Technology, 2021 - 2033 (USD Million)
- Table 39 France body fluid collection and diagnostics market, by Product, 2021 - 2033 (USD Million)
- Table 40 France body fluid collection and diagnostics market, by Application, 2021 - 2033 (USD Million)
- Table 41 Italy body fluid collection and diagnostics market, by Sample, 2021 - 2033 (USD Million)
- Table 42 Italy body fluid collection and diagnostics market, by Technology, 2021 - 2033 (USD Million)
- Table 43 Italy body fluid collection and diagnostics market, by Product, 2021 - 2033 (USD Million)
- Table 44 Italy body fluid collection and diagnostics market, by Application, 2021 - 2033 (USD Million)
- Table 45 Spain body fluid collection and diagnostics market, by Sample, 2021 - 2033 (USD Million)
- Table 46 Spain body fluid collection and diagnostics market, by Technology, 2021 - 2033 (USD Million)
- Table 47 Spain body fluid collection and diagnostics market, by Product, 2021 - 2033 (USD Million)
- Table 48 Spain body fluid collection and diagnostics market, by Application, 2021 - 2033 (USD Million)
- Table 49 Denmark body fluid collection and diagnostics market, by Sample, 2021 - 2033 (USD Million)
- Table 50 Denmark body fluid collection and diagnostics market, by Technology, 2021 - 2033 (USD Million)
- Table 51 Denmark body fluid collection and diagnostics market, by Product, 2021 - 2033 (USD Million)
- Table 52 Denmark body fluid collection and diagnostics market, by Application, 2021 - 2033 (USD Million)
- Table 53 Sweden body fluid collection and diagnostics market, by Sample, 2021 - 2033 (USD Million)
- Table 54 Sweden body fluid collection and diagnostics market, by Technology, 2021 - 2033 (USD Million)
- Table 55 Sweden body fluid collection and diagnostics market, by Product, 2021 - 2033 (USD Million)
- Table 56 Sweden body fluid collection and diagnostics market, by Application, 2021 - 2033 (USD Million)
- Table 57 Norway body fluid collection and diagnostics market, by Sample, 2021 - 2033 (USD Million)
- Table 58 Norway body fluid collection and diagnostics market, by Technology, 2021 - 2033 (USD Million)
- Table 59 Norway body fluid collection and diagnostics market, by Product, 2021 - 2033 (USD Million)
- Table 60 Norway body fluid collection and diagnostics market, by Application, 2021 - 2033 (USD Million)
- Table 61 Asia Pacific body fluid collection and diagnostics market, by Country, 2021 - 2033 (USD Million)
- Table 62 Asia Pacific body fluid collection and diagnostics market, by Sample, 2021 - 2033 (USD Million)
- Table 63 Asia Pacific body fluid collection and diagnostics market, by Technology, 2021 - 2033 (USD Million)
- Table 64 Asia Pacific body fluid collection and diagnostics market, by Product, 2021 - 2033 (USD Million)
- Table 65 Asia Pacific body fluid collection and diagnostics market, by Application, 2021 - 2033 (USD Million)
- Table 66 China body fluid collection and diagnostics market, by Sample, 2021 - 2033 (USD Million)
- Table 67 China body fluid collection and diagnostics market, by Technology, 2021 - 2033 (USD Million)
- Table 68 China body fluid collection and diagnostics market, by Product, 2021 - 2033 (USD Million)
- Table 69 China body fluid collection and diagnostics market, by Application, 2021 - 2033 (USD Million)
- Table 70 Japan body fluid collection and diagnostics market, by Sample, 2021 - 2033 (USD Million)
- Table 71 Japan body fluid collection and diagnostics market, by Technology, 2021 - 2033 (USD Million)
- Table 72 Japan body fluid collection and diagnostics market, by Product, 2021 - 2033 (USD Million)
- Table 73 Japan body fluid collection and diagnostics market, by Application, 2021 - 2033 (USD Million)
- Table 74 India body fluid collection and diagnostics market, by Sample, 2021 - 2033 (USD Million)
- Table 75 India body fluid collection and diagnostics market, by Technology, 2021 - 2033 (USD Million)
- Table 76 India body fluid collection and diagnostics market, by Product, 2021 - 2033 (USD Million)
- Table 77 India body fluid collection and diagnostics market, by Application, 2021 - 2033 (USD Million)
- Table 78 South Korea body fluid collection and diagnostics market, by Sample, 2021 - 2033 (USD Million)
- Table 79 South Korea body fluid collection and diagnostics market, by Technology, 2021 - 2033 (USD Million)
- Table 80 South Korea body fluid collection and diagnostics market, by Product, 2021 - 2033 (USD Million)
- Table 81 South Korea body fluid collection and diagnostics market, by Application, 2021 - 2033 (USD Million)
- Table 82 Australia body fluid collection and diagnostics market, by Sample, 2021 - 2033 (USD Million)
- Table 83 Australia body fluid collection and diagnostics market, by Technology, 2021 - 2033 (USD Million)
- Table 84 Australia body fluid collection and diagnostics market, by Product, 2021 - 2033 (USD Million)
- Table 85 Australia body fluid collection and diagnostics market, by Application, 2021 - 2033 (USD Million)
- Table 86 Thailand body fluid collection and diagnostics market, by Sample, 2021 - 2033 (USD Million)
- Table 87 Thailand body fluid collection and diagnostics market, by Technology, 2021 - 2033 (USD Million)
- Table 88 Thailand body fluid collection and diagnostics market, by Product, 2021 - 2033 (USD Million)
- Table 99 Thailand body fluid collection and diagnostics market, by Application, 2021 - 2033 (USD Million)
- Table 100 Latin America body fluid collection and diagnostics market, by Country, 2021 - 2033 (USD Million)
- Table 101 Latin America body fluid collection and diagnostics market, by Sample, 2021 - 2033 (USD Million)
- Table 102 Latin America body fluid collection and diagnostics market, by Technology, 2021 - 2033 (USD Million)
- Table 103 Latin America body fluid collection and diagnostics market, by Product, 2021 - 2033 (USD Million)
- Table 104 Latin America body fluid collection and diagnostics market, by Application, 2021 - 2033 (USD Million)
- Table 105 Brazil body fluid collection and diagnostics market, by Sample, 2021 - 2033 (USD Million)
- Table 106 Brazil body fluid collection and diagnostics market, by Technology, 2021 - 2033 (USD Million)
- Table 107 Brazil body fluid collection and diagnostics market, by Product, 2021 - 2033 (USD Million)
- Table 108 Brazil body fluid collection and diagnostics market, by Application, 2021 - 2033 (USD Million)
- Table 109 Argentina body fluid collection and diagnostics market, by Sample, 2021 - 2033 (USD Million)
- Table 110 Argentina body fluid collection and diagnostics market, by Technology, 2021 - 2033 (USD Million)
- Table 111 Argentina body fluid collection and diagnostics market, by Product, 2021 - 2033 (USD Million)
- Table 112 Argentina body fluid collection and diagnostics market, by Application, 2021 - 2033 (USD Million)
- Table 113 Middle East & Africa body fluid collection and diagnostics market, by Country, 2021 - 2033 (USD Million)
- Table 114 Middle East & Africa body fluid collection and diagnostics market, by Sample, 2021 - 2033 (USD Million)
- Table 115 Middle East & Africa body fluid collection and diagnostics market, by Technology, 2021 - 2033 (USD Million)
- Table 116 Middle East & Africa body fluid collection and diagnostics market, by Product, 2021 - 2033 (USD Million)
- Table 117 Middle East & Africa body fluid collection and diagnostics market, by Application, 2021 - 2033 (USD Million)
- Table 118 South Africa body fluid collection and diagnostics market, by Sample, 2021 - 2033 (USD Million)
- Table 119 South Africa body fluid collection and diagnostics market, by Technology, 2021 - 2033 (USD Million)
- Table 120 South Africa body fluid collection and diagnostics market, by Product, 2021 - 2033 (USD Million)
- Table 121 South Africa body fluid collection and diagnostics market, by Application, 2021 - 2033 (USD Million)
- Table 122 Saudi Arabia body fluid collection and diagnostics market, by Sample, 2021 - 2033 (USD Million)
- Table 123 Saudi Arabia body fluid collection and diagnostics market, by Technology, 2021 - 2033 (USD Million)
- Table 124 Saudi Arabia body fluid collection and diagnostics market, by Product, 2021 - 2033 (USD Million)
- Table 125 Saudi Arabia body fluid collection and diagnostics market, by Application, 2021 - 2033 (USD Million)
- Table 126 UAE body fluid collection and diagnostics market, by Sample, 2021 - 2033 (USD Million)
- Table 127 UAE body fluid collection and diagnostics market, by Technology, 2021 - 2033 (USD Million)
- Table 128 UAE body fluid collection and diagnostics market, by Product, 2021 - 2033 (USD Million)
- Table 130 UAE body fluid collection and diagnostics market, by Application, 2021 - 2033 (USD Million)
- Table 131 Kuwait body fluid collection and diagnostics market, by Sample, 2021 - 2033 (USD Million)
- Table 132 Kuwait body fluid collection and diagnostics market, by Technology, 2021 - 2033 (USD Million)
- Table 133 Kuwait body fluid collection and diagnostics market, by Product, 2021 - 2033 (USD Million)
- Table 134 Kuwait body fluid collection and diagnostics market, by Application, 2021 - 2033 (USD Million)
List of Figures
- Fig. 1 Market research process
- Fig. 2 Information Procurement
- Fig. 3 Primary Research Pattern
- Fig. 4 Market Research Approaches
- Fig. 5 Value Chain-Based Sizing & Forecasting
- Fig. 6 Market Formulation & Validation
- Fig. 7 Body Fluid Collection And Diagnostics Market Segmentation
- Fig. 8 Market Snapshot, 2022
- Fig. 9 Market Trends & Outlook
- Fig. 10 Market Driver Relevance Analysis (Current & Future Impact)
- Fig. 11 Market Restraint Relevance Analysis (Current & Future Impact)
- Fig. 12 Market Challenge Relevance Analysis (Current & Future Impact)
- Fig. 13 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
- Fig. 14 Porter's Five Forces Analysis
- Fig. 15 Global body fluid collection and diagnostics market, Sample Movement Analysis
- Fig. 16 Global body fluid collection and diagnostics market, for Blood, 2021 - 2033 (USD Million)
- Fig. 17 Global body fluid collection and diagnostics market, for Urine, 2021 - 2033 (USD Million)
- Fig. 18 Global body fluid collection and diagnostics market, for Saliva, 2021 - 2033 (USD Million)
- Fig. 19 Global body fluid collection and diagnostics market, for Cerebrospinal Fluid, 2021 - 2033 (USD Million)
- Fig. 20 Global body fluid collection and diagnostics market, Product Movement Analysis
- Fig. 21 Global body fluid collection and diagnostics market, for Tests/Services, Movement Analysis
- Fig. 22 Global body fluid collection and diagnostics market, for Kits & Consumables, 2021 - 2033 (USD Million)
- Fig. 23 Global body fluid collection and diagnostics market, for Instruments, 2021 - 2033 (USD
- Fig. 24 Global body fluid collection and diagnostics market, Technology Movement Analysis
- Fig. 25 Global body fluid collection and diagnostics market, for Next Generation Sequencing, 2021 - 2033 (USD Million)
- Fig. 26 Global body fluid collection and diagnostics market, for PCR - based Testing, 2021 - 2033 (USD Million)
- Fig. 27 Global body fluid collection and diagnostics market, for FISH, 2021 - 2033 (USD Million)
- Fig. 28 Global body fluid collection and diagnostics market, for Others, 2021 - 2033 (USD Million)
- Fig. 29 Global body fluid collection and diagnostics market, Application Movement Analysis
- Fig. 30 Global body fluid collection and diagnostics market, for Diagnostics & Monitoring, 2021 - 2033 (USD Million)
- Fig. 31 Global body fluid collection and diagnostics market, for Therapeutic Decision Making, 2021 - 2033 (USD Million)
- Fig. 32 Global body fluid collection and diagnostics market, for Prognostics & Screening, 2018- 2033 Million)
- Fig. 33 Regional Marketplace: Key Takeaways
- Fig. 34 Regional Outlook, 2024 & 2033
- Fig. 35 Global Body Fluid Collection And Diagnostics Market, Region Movement Analysis
- Fig. 36 North America body fluid collection and diagnostics market, 2021 - 2033 (USD Million)
- Fig. 37 U.S. body fluid collection and diagnostics market, 2021 - 2033 (USD Million)
- Fig. 38 Canada body fluid collection and diagnostics market, 2021 - 2033 (USD Million)
- Fig. 39 Mexico body fluid collection and diagnostics market, 2021 - 2033 (USD Million)
- Fig. 40 Europe body fluid collection and diagnostics market, 2021 - 2033 (USD Million)
- Fig. 41 Germany body fluid collection and diagnostics market, 2021 - 2033 (USD Million)
- Fig. 42 UK body fluid collection and diagnostics market, 2021 - 2033 (USD Million)
- Fig. 43 France body fluid collection and diagnostics market, 2021 - 2033 (USD Million)
- Fig. 44 Italy body fluid collection and diagnostics market, 2021 - 2033 (USD Million)
- Fig. 45 Spain body fluid collection and diagnostics market, 2021 - 2033 (USD Million)
- Fig. 46 Denmark body fluid collection and diagnostics market, 2021 - 2033 (USD Million)
- Fig. 47 Sweden body fluid collection and diagnostics market, 2021 - 2033 (USD Million)
- Fig. 48 Norway body fluid collection and diagnostics market, 2021 - 2033 (USD Million)
- Fig. 49 Asia Pacific body fluid collection and diagnostics market, 2021 - 2033 (USD Million)
- Fig. 50 Japan body fluid collection and diagnostics market, 2021 - 2033 (USD Million)
- Fig. 51 China body fluid collection and diagnostics market, 2021 - 2033 (USD Million)
- Fig. 52 India body fluid collection and diagnostics market, 2021 - 2033 (USD Million)
- Fig. 53 Australia body fluid collection and diagnostics market, 2021 - 2033 (USD Million)
- Fig. 54 South Korea body fluid collection and diagnostics market, 2021 - 2033 (USD Million)
- Fig. 55 Thailand body fluid collection and diagnostics market, 2021 - 2033 (USD Million)
- Fig. 56 Latin America body fluid collection and diagnostics market, 2021 - 2033 (USD Million)
- Fig. 57 Brazil body fluid collection and diagnostics market, 2021 - 2033 (USD Million)
- Fig. 58 Argentina body fluid collection and diagnostics market, 2021 - 2033 (USD Million)
- Fig. 59 Middle East and Africa body fluid collection and diagnostics market, 2021 - 2033 (USD Million)
- Fig. 60 South Africa body fluid collection and diagnostics market, 2021 - 2033 (USD Million)
- Fig. 61 Saudi Arabia body fluid collection and diagnostics market, 2021 - 2033 (USD Million)
- Fig. 62 UAE body fluid collection and diagnostics market, 2021 - 2033 (USD Million)
- Fig. 63 Kuwait body fluid collection and diagnostics market, 2021 - 2033 (USD Million)
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.